News | Radiation Therapy | December 23, 2016

Scientists Investigate Cancer Radiotherapy to Make Improvements

A University of Rochester Medical Center study shows that when tumors are treated with radiotherapy, the benefits can be hijacked by the treatment's counteraction to trigger inflammation and dampen the body's immune response.

Published by the journal Oncotarget, the study suggests that radiotherapy (also known as radiation treatment) could be more effective if it was combined with a drug that would block a specific cell that is responsible for dulling the immune system. In mice, the research team experimented by delivering an immunotherapy two days prior to radiotherapy and saw significant benefits for many different types of cancer.

Led by Scott A. Gerber, Ph.D., assistant professor in the Department of Surgery, and graduate student Kelli A. Connolly, the research fills an important gap in knowledge. Scientists already know that radiotherapy stimulates anti-tumor cells and helps to control cancer's growth. What is less understood is why radiotherapy cannot cure cancer.

The answer may lie with how the immune system responds to radiotherapy when a tumor is present. The URMC and Wilmot Cancer Institute scientists discovered that radiation increases the circulation of certain harmful inflammatory cells and changes the way the immune system rallies against cancer. In many patients, the circulating level of these cells (called monocytes) is already high prior to cancer treatment and sometimes indicates a poor prognosis.

Gerber believes that the abundance of these cells, which can be measured in a simple blood test, could identify patients who might benefit most from blocking them, allowing the immune system to fight the disease in combination with radiotherapy. Because these inflammatory cells express a unique protein on their surface, they are an easy target for medications, the study said. "Our observations of what happens during radiotherapy when cells are recruited to the tumor site and surrounding tissue has intriguing implications for how to improve treatment," said Gerber, who also has an appointment in the URMC Department of Microbiology and Immunology.

For more information: www.urmc.rochester.edu

Related Content

Early Stereotactic Radiosurgery Improves Outcomes for Nonfunctioning Pituitary Macroadenoma Patients
News | Radiation Therapy | April 27, 2017
Jason P. Sheehan, M.D., Ph.D., FAANS, winner of the Leksell Radiosurgery Award, presented his research on stereotactic...
Nine New Disease Sites Added to the NCCN Radiation Therapy Compendium
News | Radiation Therapy | April 26, 2017
April 26, 2017 — The National Comprehensive Cancer Network (NCCN) continues to build its NCCN Radiation Therapy Compe
Precision Medicine Poised to Change Brain Tumor Diagnostics and Treatment
News | Radiation Therapy | April 26, 2017
April 26, 2017 — A new report on the brain cancer diagnostics market projects that up to 78,000 new cases of primary
Elekta Highlights Leksell Vantage System for Stereotactic Neurosurgery at AANS 2017
News | Radiation Therapy | April 24, 2017
Elekta announced that its Leksell Vantage Stereotactic System, will be highlighted at the American Association of...
New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017
iCAD Inc. announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft...
RaySearch and MD Anderson Collaborate on Development of RayCare
News | Oncology Information Management Systems (OIMS) | April 18, 2017
The University of Texas MD Anderson Cancer Center in Houston, Texas, will collaborate with RaySearch on the development...
New ASTRO Guideline Establishes Standard of Care for Curative Oropharyngeal Cancer Treatment With Radiotherapy
News | Radiation Therapy | April 17, 2017
April 17, 2017 — The American Society for Radiation Oncology (ASTRO) has issued a new clinical guideline for the mana
radiotherapy, radiation therapy, CHLA, Children's Hospital Los Angeles study, young children, brain tumors, outcomes, Pediatric Blood & Cancer

Image courtesy of CHLA.

News | Radiation Therapy | April 06, 2017
A team of investigators has determined that young children participating in a clinical trial to assess the...
Mevion, S250i proton therapy system, Hyperscan pencil beam scanning, installation, MedStar Georgetown University Hospital
News | Proton Therapy | April 04, 2017
April 4, 2017 — Mevion Medical Systems announced the installation of the first Mevion S250i...
high-intensity focused ultrasound, HIFU, prostate tissue ablation, after radiotherapy, EDAP TMS SA, Ablatherm, British Journal of Urology International study
News | Focused Ultrasound Therapy | March 29, 2017
EDAP TMS SA announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU (high-intensity...
Overlay Init